BioCatalyst

Maridebart Cafraglutide — catalyst calendar

2 verified catalyst event(s) referencing Maridebart Cafraglutide, each linked to its official source. Verified as of 2026-10-01.

Upcoming

DateEventCompanyDrugOfficial source & verification
2027-01-21
in 4mo
ESTIMATED
 READOUT
Evaluation of Maridebart Cafraglutide in Adult Participants Without Type 2 Diabe
Phase 3 · Obesity
 AMGN AMGEN INC Maridebart Cafraglutide ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
2027-01-21
in 4mo
ESTIMATED
 READOUT
Efficacy and Safety of Maridebart Cafraglutide in Adult Participants With Type 2
Phase 3 · Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
 AMGN AMGEN INC Maridebart cafraglutide ClinicalTrials.gov ↗
✓ Source-checked 2026-10-01
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.